APHARMA Trademark

Trademark Overview


On Wednesday, January 31, 2024, a trademark application was filed for APHARMA with the United States Patent and Trademark Office. The USPTO has given the APHARMA trademark a serial number of 98385017. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 29, 2024. This trademark is owned by APharma LLC. The APHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Supplements, medications
apharma

General Information


Serial Number98385017
Word MarkAPHARMA
Filing DateWednesday, January 31, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, August 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSupplements, medications

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAPharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDover, DE 19901

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2024NEW APPLICATION ENTERED
Saturday, June 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 26, 2024ASSIGNED TO EXAMINER
Thursday, August 29, 2024NON-FINAL ACTION WRITTEN
Thursday, August 29, 2024NON-FINAL ACTION E-MAILED
Thursday, August 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


apharma medications supplements